- Home
- WEST vs TERN Comparison
WEST vs TERN Comparison
Compare WEST & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- TERN
- Stock Information
- Founded
- WEST 2009
- TERN 2017
- Country
- WEST United States
- TERN United States
- Employees
- WEST N/A
- TERN N/A
- Industry
- WEST Beverages (Production/Distribution)
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- TERN Health Care
- Exchange
- WEST Nasdaq
- TERN Nasdaq
- Market Cap
- WEST 640.7M
- TERN 531.9M
- IPO Year
- WEST N/A
- TERN 2021
- Fundamental
- Price
- WEST $6.65
- TERN $5.83
- Analyst Decision
- WEST Strong Buy
- TERN Buy
- Analyst Count
- WEST 5
- TERN 5
- Target Price
- WEST $10.60
- TERN $15.63
- AVG Volume (30 Days)
- WEST 297.3K
- TERN 953.6K
- Earning Date
- WEST 08-07-2025
- TERN 08-12-2025
- Dividend Yield
- WEST N/A
- TERN N/A
- EPS Growth
- WEST N/A
- TERN N/A
- EPS
- WEST N/A
- TERN N/A
- Revenue
- WEST $872,022,000.00
- TERN N/A
- Revenue This Year
- WEST $22.72
- TERN N/A
- Revenue Next Year
- WEST $14.75
- TERN N/A
- P/E Ratio
- WEST N/A
- TERN N/A
- Revenue Growth
- WEST 2.38
- TERN N/A
- 52 Week Low
- WEST $5.28
- TERN $1.87
- 52 Week High
- WEST $10.10
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- WEST 51.41
- TERN 68.08
- Support Level
- WEST $6.86
- TERN $5.57
- Resistance Level
- WEST $7.31
- TERN $6.10
- Average True Range (ATR)
- WEST 0.27
- TERN 0.28
- MACD
- WEST 0.04
- TERN -0.02
- Stochastic Oscillator
- WEST 49.62
- TERN 72.66
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.